Catalyst Biosciences, Inc. (CBIO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 01:20PM EST. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 17.32M |
| Enterprise Value | -5.39M |
| Trailing P/E | 1.45 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.37 |
| Price/Book (mrq) | 0.59 |
| Enterprise Value/Revenue | -1.67 |
| Enterprise Value/EBITDA | -0.44 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.70 |
| 52-Week Change 3 | 74.30% |
| S&P500 52-Week Change 3 | -13.20% |
| 52 Week High 3 | 0.6200 |
| 52 Week Low 3 | 0.0920 |
| 50-Day Moving Average 3 | 0.5481 |
| 200-Day Moving Average 3 | 0.3699 |
Share Statistics
| Avg Vol (3 month) 3 | 897.6k |
| Avg Vol (10 day) 3 | 98.78k |
| Shares Outstanding 5 | 31.49M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 25.37M |
| % Held by Insiders 1 | 11.36% |
| % Held by Institutions 1 | 24.99% |
| Shares Short (Nov 14, 2022) 4 | 509.33k |
| Short Ratio (Nov 14, 2022) 4 | 3.25 |
| Short % of Float (Nov 14, 2022) 4 | 1.63% |
| Short % of Shares Outstanding (Nov 14, 2022) 4 | 1.62% |
| Shares Short (prior month Oct 13, 2022) 4 | 531.45k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 1.43 |
| Trailing Annual Dividend Yield 3 | 259.95% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Sept 19, 2022 |
| Ex-Dividend Date 4 | Sept 20, 2022 |
| Last Split Factor 2 | 3803:1000 |
| Last Split Date 3 | Sept 20, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Sept 29, 2022 |
Profitability
| Profit Margin | 367.44% |
| Operating Margin (ttm) | -1,259.34% |
Management Effectiveness
| Return on Assets (ttm) | -46.47% |
| Return on Equity (ttm) | 26.37% |
Income Statement
| Revenue (ttm) | 3.23M |
| Revenue Per Share (ttm) | 0.10 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -64.91M |
| EBITDA | -40.39M |
| Net Income Avi to Common (ttm) | 11.88M |
| Diluted EPS (ttm) | 0.3800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 23.09M |
| Total Cash Per Share (mrq) | 0.73 |
| Total Debt (mrq) | 381k |
| Total Debt/Equity (mrq) | 1.30 |
| Current Ratio (mrq) | 18.40 |
| Book Value Per Share (mrq) | 0.93 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -49.3M |
| Levered Free Cash Flow (ttm) | -35.22M |
© 2022 Yahoo. All rights reserved.
